The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.

Bibliographic Details
Published in:	Cancer (0008543X) Vol. 125; no. 10; pp. 1674 - 1683
Main Authors:	D'Adda, Mariella, Farina, Mirko, Schieppati, Francesca, Borlenghi, Erika, Bottelli, Chiara, Cerqui, Elisa, Ferrari, Samantha, Gramegna, Doriana, Pagani, Chiara, Passi, Angela, Maifredi, Adriana, Tucci, Alessandra, Capucci, Maria A., Ruggeri, Giuseppina, Rossi, Giuseppe
Format:	Journal Article
Published:	Wiley-Blackwell May2019
Online Access:	View this record in EBSCOhost

Internet